This is a recruiting trial registration with no results reported; it is a feasibility study of a novel device in early development, designed to assess safety and tolerability rather than efficacy.
Reported
Estimated sample size60
Treatment duration (primary outco…10 minutes
Primary outcome: Adverse events t…CTCAE v4.0 grades 3, 4, or 5